Paediatrics Search
Paediatrics Paediatrics
bronchiolitis
BRONCHIOLITIS
Bronchiolitis is a clinical diagnosis preceding upper respiratory illness and/or rhinorrhea.
Signs of respiratory illness which may include wheezing, retractions, oxygen desaturation, color change, nasal flaring.
There is also presence of apnea especially in premature or low birthweight infants, signs of dehydration and exposure to persons with viral upper respiratory infections.
Symptoms are usually worst on the 3rd-5th day of illness and then improve gradually.

Bronchiolitis Drug Information

Drug Information

Indication: Management of reversible bronchospasm associated w/ obstructive airway disease in patients who require more th...

Indication: Tab/syr: Relief of all bronchial asthma, chronic bronchitis & emphysema. Evohaler: Symptomatic relief &...

Indication: Acute & chronic bronchopulmonary diseases associated w/ abnormal mucus secretion & impaired mucus tran...

Indication: Acute & chronic diseases of the resp tract especially chronic bronchitis, asthmatoid bronchitis, bronchial...

Axcel Dextrozine
dextromethorphan hydrobromide + promethazine hydro...

Indication: Relief of congestion & dry irritating cough eg, those associated w/ common cold, upper resp tract infectio...

Indication: Relief of bronchospasm in asthma, chronic bronchitis, other conditions involving airways obstruction.

Indication: Resp disorders associated w/ viscid mucus.

Indication: Relief & prevention of asthma & COPD symptoms. Relieve attacks of acute breathlessness due to reversib...

Indication: Relief & prevention of asthma symptoms.

1  /  7
1  /  7
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Preventive zinc, micronutrient powders do not improve child growth
02 Apr 2019
Using preventive zinc and micronutrient powder supplementation does not appear to improve growth in children, a recent study has found.
Rheuma drug shows disease-modifying potential for T1D
Audrey Abella, 14 Oct 2020
Findings from the phase IIa T1GER study revealed the therapeutic potential of the monoclonal antibody golimumab for children and young adults with type 1 diabetes (T1D).
Amoxicillin-clavulanate regimen for PBB: 4 weeks no better than 2 weeks
Roshini Claire Anthony, 28 Sep 2020

A 4-week course of amoxicillin-clavulanate in children with protracted bacterial bronchitis (PBB) does not improve cough resolution rates compared with a 2-week course, according to a study from Australia. However, the longer course may significantly extend time to first cough exacerbation.